Illumina, Inc.

ILMN US Health Care Life Sciences Tools & Services
S&P 400
$206.45
+2.57%
Delayed · cached 15 min
Fair Value Analysis →

Price Chart

Price50-day avg200-day avg

How to read this: the line is the closing price over time. The two dashed lines are moving averages — the average price over the last 50 and 200 trading days — which smooth out daily noise to show the broader trend. Price above its moving averages reflects recent strength; below reflects recent weakness. Use the buttons to change the time range. Prices are end-of-day, not live.

Strengths

  • Comfortable interest cover: operating profit covers interest about 8 times.
  • Return on equity is healthy at 30%.
  • Return on capital employed is healthy at 15.9%.
  • Net profit margin is strong at 19.6%.
  • Current assets comfortably cover current liabilities (current ratio 2.08).

!Watch-points

No notable watch-points flagged by the automated checks.

These points are generated automatically from the company’s reported figures to highlight what stands out. They are descriptive observations for educational purposes only — not advice or a recommendation to buy, sell, or hold.

Forensic Checks

Piotroski F-ScoreModerate
6 / 7

The F-Score adds one point for each of several year-on-year signs of improving profitability, lower leverage and better efficiency. Higher is generally stronger.

Based on 7 of the 9 signals — the rest need data not available for this stock.

These are well-known academic screening models, shown for educational context only. They describe historical financial patterns and are not predictions, advice, or a recommendation to buy, sell, or hold.

Key Ratios

Market Cap$31.17B
Current Price$ 206.45
High / Low$ 231.81 / 88.00
Stock P/E38.445065
Book Value$ 18.55
Dividend Yield0%
ROCE15.93%
ROE29.95%
Current Ratio2.08
P/B Ratio10.984304
EPS$ 5.45
PAT Margin19.57%
Cash PAT$1.12B
ICR7.99
Educational data only. Not a recommendation to buy, sell or hold any security.